Literature DB >> 7860135

Risk of ocular melanoma in relation to cutaneous and iris naevi.

V Bataille1, P Sasieni, J Cuzick, J L Hungerford, A Swerdlow, J A Bishop.   

Abstract

A case-control study was set up to assess the risk of eye melanoma in relation to the number and type of cutaneous melanocytic naevi and pigmented lesions of the iris. Cases comprised 211 unselected ocular melanoma patients attending the Ocular Oncology Clinic at Moorfields Eye Hospital, London, during November 1990 to October 1991 and diagnosed after August 1986. Hospital and general practice controls (416) were recruited in the North East Thames Region of the UK. Cutaneous naevi greater than or equal to 2 mm in diameter were counted on the skin. Clinically atypical and congenital naevi were recorded separately. Pigmented lesions of the iris were counted. The relative risk for ocular melanoma increased with numbers of atypical naevi and numbers of common naevi. Ten percent of cases but 3% of controls had at least 100 naevi of 2 mm or greater diameter. Seven percent of cases and 0.4% of controls had 4 or more atypical naevi. Pigmented lesions of the iris were significantly more common in cases than controls. Nine percent of cases had the Atypical Mole syndrome (AMS) phenotype compared with 1% of controls. Six cases had concurrent cutaneous melanoma primaries. We conclude that atypical and iris naevi are important risk factors for eye melanoma and that patients with eye melanoma are at increased risk of cutaneous melanoma. Dermatological examination for the AMS phenotype and cutaneous melanoma should be recommended in eye melanoma patients with large numbers of pigmented lesions of the skin or family history of melanoma.

Entities:  

Mesh:

Year:  1995        PMID: 7860135     DOI: 10.1002/ijc.2910600509

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  8 in total

Review 1.  Risk factors for intraocular melanoma and occupational exposure.

Authors:  J M Lutz; I A Cree; A J Foss
Journal:  Br J Ophthalmol       Date:  1999-10       Impact factor: 4.638

Review 2.  Uveal melanoma: relatively rare but deadly cancer.

Authors:  S Kaliki; C L Shields
Journal:  Eye (Lond)       Date:  2016-12-02       Impact factor: 3.775

3.  Association between posterior uveal melanoma and iris freckles, iris naevi, and choroidal naevi.

Authors:  J W Harbour; M A Brantley; H Hollingsworth; M Gordon
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

4.  Current molecular and clinical insights into uveal melanoma (Review).

Authors:  Matteo Fallico; Giuseppina Raciti; Antonio Longo; Michele Reibaldi; Vincenza Bonfiglio; Andrea Russo; Rosario Caltabiano; Giuseppe Gattuso; Luca Falzone; Teresio Avitabile
Journal:  Int J Oncol       Date:  2021-03-02       Impact factor: 5.650

5.  Robotic assisted CyberKnife radiosurgery for the treatment of iris melanoma.

Authors:  Valerie Schmelter; Sarah Heidorn; Alexander Muacevic; Siegfried G Priglinger; Paul Foerster; Raffael Liegl
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

6.  Prognostic Factors and Nomograms for Overall and Cancer-Specific Survival of Patients with Uveal Melanoma without Metastases: A SEER Analysis of 4119 Cases.

Authors:  Xin Liu; Chang Liu; Yue Shang; Lin Yang; Fengling Tan; Yong Lv
Journal:  J Ophthalmol       Date:  2022-09-14       Impact factor: 1.974

7.  Role of MC1R variants in uveal melanoma.

Authors:  N Hearle; J Humphreys; B E Damato; R Wort; R Talaban; J Wixey; H Green; D F Easton; R S Houlston
Journal:  Br J Cancer       Date:  2003-11-17       Impact factor: 7.640

8.  Epidemiological Study of Uveal Melanoma from US Surveillance, Epidemiology, and End Results Program (2010-2015).

Authors:  Yufeng Xu; Lixia Lou; Yijie Wang; Qi Miao; Kai Jin; Menglu Chen; Juan Ye
Journal:  J Ophthalmol       Date:  2020-02-19       Impact factor: 1.909

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.